Aram Adourian - BG Medicine Insider

BG Medicine Inc -- USA Stock  

USD 0.08  0.015  23.08%

Chief Scientific Officer and Sr. VP

Dr. Aram Adourian, Ph.D., is Senior Vice President, Chief Scientific Officer of BG Medicine, Inc., since October 2012. Dr. Adourian worked as our Senior Director, Technology Assessment. In October 2003, Dr. Adourian was promoted to Vice President, Computational Sciences and served in such position until January 2007, when he was designated a general Vice President and served in such position until January 2009. In January 2009, Dr. Adourian was appointed as our Vice President, Scientific Affairs. In October 2012, Dr. Adourian was appointed as our Senior Vice President, Chief Scientific Officer. In May 2016, Dr. Adourian terminated his employment with the Company but he continues to serve as the Chief Scientific Officer of the Company on a consulting basis. Prior to joining us, Dr. Adourian worked at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. While at MIT, Dr. Adourian served as Project Manager for Bioinformatics specializing in the development of novel systems and approaches for biomolecular sequencing, analysis and modeling
Age: 45  SVP Since 2012  Ph.D    
781 890-1199  www.bg-medicine.com
Adourian earned his Ph.D. at Harvard University in Statistical Physics, where he was a recipient of the Rudenberg Research Prize, and received his undergraduate degree in Physics from Cornell University.

Management Efficiency

The company has return on total asset (ROA) of (75.95) % which means that it has lost $75.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (902.64) % meaning that it created substantial loss on money invested by shareholders.

Entity Summary

BG Medicine, Inc. engages in development and commercialization of diagnostic solutions used to guide the patients suffering from heart failure and related disorders in the United States. BG Medicine Inc (BGMD) is traded on OTC Market in USA. It is located in MASSACHUSETTS, U.S.A and employs 5 people. BG Medicine is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Idea Analyzer Now
   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Hide  View All  NextLaunch Idea Analyzer
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add BG Medicine Inc to your portfolio

Top Management

BG Medicine Inc Leadership Team
Harrison Bains, Director, MBA
Timothy Harris, Director, Ph.D
James Connor, Director
Harry Wilcox, Director
Stelios Papadopoulos, Director, MBA
Aram Adourian, SVP, Ph.D
Stephen Hall, CFO, MBA
Jeffrey Luber, Director, MBA
Raul Diaz, VP
Paul Sohmer, CEO
Noubar Afeyan, Founder
James OConnor, Director

Stock Performance

BG Medicine Performance Indicators